Current treatment status-Undergoing active treatment,Progressive despite treatment Posts on Medivizor

Posted by Medivizor on Sep 19, 2015 in Prostate cancer | 0 comments

In a nutshell The authors determined the benefit of combination treatment with gemcitabine (Gemzar) and oxaliplatin (Eloxatin) in hormone resistant (castration-resistant) prostate cancer. Some background Hormone therapy is a common treatment for prostate cancer. It targets the male sex hormones active in prostate cancer, such as testosterone....